Ursodeoxycholate increases cytosolic calcium concentration and activates CI- currents in a biliary cell line

Gayle H. Shimokura, James M. McGill, Thorsten Schlenker, J. Gregory Fitz

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background & Aims: Ursodeoxycholate (UDC) stimulates a bicarbonate-rich choleresis, but the cellular mechanisms involved are not fully established. Because ductular secretion also increases biliary HCO3 - concentration, the purpose of this study was to evaluate whether UDC has direct effects on duct cells by measuring intracellular calcium concentration ([Ca2+]i) and membrane CI- permeability in Mz-ChA-1 human cholangiocarcinoma cells. Methods: Intracellular calcium levels were measured using fura-2 fluorescence. Membrane CI- permeability was assessed in subconfluent monolayers using 125I efflux and in individual cells using whole-cell patch clamp techniques. Results: Exposure to UDC (2.5 mmol/L) increased [Ca2+]i from 180 ± 25 to 639 ± 84 nmol/L due to release of Ca2+ from intracellular stores and stimulated 125I efflux approximately threefold above basal levels. Exposure to extracellular (1.25 mmol/L) or intracellular (100 μmol/L) UDC activated currents carried by CI- ions; intracellular UDC increased current density from 4.7 ± 1.3 to 32.5 ± 8.8 pA/pF. UDC-stimulated currents were inhibited by chelation of intracellular calcium. Conclusions: UDC in pharmacological concentrations increases [Ca2+]i and stimulates CI- efflux through opening of CI- channels in biliary cells. We speculate that UDC could increase bile flow by direct stimulation of ductular secretion and may be of therapeutic benefit to patients with cystic fibrosis who have impaired adenosine 3′,5′-cyclic monophosphate-dependent biliary secretion.

Original languageEnglish (US)
Pages (from-to)965-972
Number of pages8
JournalGastroenterology
Volume109
Issue number3
DOIs
StatePublished - 1995

Fingerprint

Calcium
Cell Line
Permeability
Membranes
Cholangiocarcinoma
Fura-2
Patch-Clamp Techniques
Bicarbonates
Cystic Fibrosis
Bile
Adenosine
Fluorescence
Pharmacology
Ions
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Ursodeoxycholate increases cytosolic calcium concentration and activates CI- currents in a biliary cell line. / Shimokura, Gayle H.; McGill, James M.; Schlenker, Thorsten; Fitz, J. Gregory.

In: Gastroenterology, Vol. 109, No. 3, 1995, p. 965-972.

Research output: Contribution to journalArticle

Shimokura, Gayle H. ; McGill, James M. ; Schlenker, Thorsten ; Fitz, J. Gregory. / Ursodeoxycholate increases cytosolic calcium concentration and activates CI- currents in a biliary cell line. In: Gastroenterology. 1995 ; Vol. 109, No. 3. pp. 965-972.
@article{eb1ca5734d994c71b37a951978a5bfaa,
title = "Ursodeoxycholate increases cytosolic calcium concentration and activates CI- currents in a biliary cell line",
abstract = "Background & Aims: Ursodeoxycholate (UDC) stimulates a bicarbonate-rich choleresis, but the cellular mechanisms involved are not fully established. Because ductular secretion also increases biliary HCO3 - concentration, the purpose of this study was to evaluate whether UDC has direct effects on duct cells by measuring intracellular calcium concentration ([Ca2+]i) and membrane CI- permeability in Mz-ChA-1 human cholangiocarcinoma cells. Methods: Intracellular calcium levels were measured using fura-2 fluorescence. Membrane CI- permeability was assessed in subconfluent monolayers using 125I efflux and in individual cells using whole-cell patch clamp techniques. Results: Exposure to UDC (2.5 mmol/L) increased [Ca2+]i from 180 ± 25 to 639 ± 84 nmol/L due to release of Ca2+ from intracellular stores and stimulated 125I efflux approximately threefold above basal levels. Exposure to extracellular (1.25 mmol/L) or intracellular (100 μmol/L) UDC activated currents carried by CI- ions; intracellular UDC increased current density from 4.7 ± 1.3 to 32.5 ± 8.8 pA/pF. UDC-stimulated currents were inhibited by chelation of intracellular calcium. Conclusions: UDC in pharmacological concentrations increases [Ca2+]i and stimulates CI- efflux through opening of CI- channels in biliary cells. We speculate that UDC could increase bile flow by direct stimulation of ductular secretion and may be of therapeutic benefit to patients with cystic fibrosis who have impaired adenosine 3′,5′-cyclic monophosphate-dependent biliary secretion.",
author = "Shimokura, {Gayle H.} and McGill, {James M.} and Thorsten Schlenker and Fitz, {J. Gregory}",
year = "1995",
doi = "10.1016/0016-5085(95)90407-7",
language = "English (US)",
volume = "109",
pages = "965--972",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Ursodeoxycholate increases cytosolic calcium concentration and activates CI- currents in a biliary cell line

AU - Shimokura, Gayle H.

AU - McGill, James M.

AU - Schlenker, Thorsten

AU - Fitz, J. Gregory

PY - 1995

Y1 - 1995

N2 - Background & Aims: Ursodeoxycholate (UDC) stimulates a bicarbonate-rich choleresis, but the cellular mechanisms involved are not fully established. Because ductular secretion also increases biliary HCO3 - concentration, the purpose of this study was to evaluate whether UDC has direct effects on duct cells by measuring intracellular calcium concentration ([Ca2+]i) and membrane CI- permeability in Mz-ChA-1 human cholangiocarcinoma cells. Methods: Intracellular calcium levels were measured using fura-2 fluorescence. Membrane CI- permeability was assessed in subconfluent monolayers using 125I efflux and in individual cells using whole-cell patch clamp techniques. Results: Exposure to UDC (2.5 mmol/L) increased [Ca2+]i from 180 ± 25 to 639 ± 84 nmol/L due to release of Ca2+ from intracellular stores and stimulated 125I efflux approximately threefold above basal levels. Exposure to extracellular (1.25 mmol/L) or intracellular (100 μmol/L) UDC activated currents carried by CI- ions; intracellular UDC increased current density from 4.7 ± 1.3 to 32.5 ± 8.8 pA/pF. UDC-stimulated currents were inhibited by chelation of intracellular calcium. Conclusions: UDC in pharmacological concentrations increases [Ca2+]i and stimulates CI- efflux through opening of CI- channels in biliary cells. We speculate that UDC could increase bile flow by direct stimulation of ductular secretion and may be of therapeutic benefit to patients with cystic fibrosis who have impaired adenosine 3′,5′-cyclic monophosphate-dependent biliary secretion.

AB - Background & Aims: Ursodeoxycholate (UDC) stimulates a bicarbonate-rich choleresis, but the cellular mechanisms involved are not fully established. Because ductular secretion also increases biliary HCO3 - concentration, the purpose of this study was to evaluate whether UDC has direct effects on duct cells by measuring intracellular calcium concentration ([Ca2+]i) and membrane CI- permeability in Mz-ChA-1 human cholangiocarcinoma cells. Methods: Intracellular calcium levels were measured using fura-2 fluorescence. Membrane CI- permeability was assessed in subconfluent monolayers using 125I efflux and in individual cells using whole-cell patch clamp techniques. Results: Exposure to UDC (2.5 mmol/L) increased [Ca2+]i from 180 ± 25 to 639 ± 84 nmol/L due to release of Ca2+ from intracellular stores and stimulated 125I efflux approximately threefold above basal levels. Exposure to extracellular (1.25 mmol/L) or intracellular (100 μmol/L) UDC activated currents carried by CI- ions; intracellular UDC increased current density from 4.7 ± 1.3 to 32.5 ± 8.8 pA/pF. UDC-stimulated currents were inhibited by chelation of intracellular calcium. Conclusions: UDC in pharmacological concentrations increases [Ca2+]i and stimulates CI- efflux through opening of CI- channels in biliary cells. We speculate that UDC could increase bile flow by direct stimulation of ductular secretion and may be of therapeutic benefit to patients with cystic fibrosis who have impaired adenosine 3′,5′-cyclic monophosphate-dependent biliary secretion.

UR - http://www.scopus.com/inward/record.url?scp=0029126559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029126559&partnerID=8YFLogxK

U2 - 10.1016/0016-5085(95)90407-7

DO - 10.1016/0016-5085(95)90407-7

M3 - Article

VL - 109

SP - 965

EP - 972

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -